Top Anti Cancer Imported Medicine Drugs in India - Pharama Five
Help Desk :+916374297988

Pharma Five is a registered firm based in India. We specialize in Named Patient Imports, Imported cancer drugs, Imported medicines in india.

Contact Us Pharma Five Door No. 74, Old No. 26, Fagun Mansion, 3rd Floor, Ethiraj Salai, Egmore, Chennai - 600008 +916374297988 info@pharmafive.org

Best Alunbrig (Brigatinib) Medicine in India

Buy Alunbrig (Brigatinib) Medicine in India

Alunbrig (Brigatinib)

Medicine name : Alunbrig

Generic name : Brigatinib

Manufactured By : Takeda

Indications : Anaplastic Lymphoma,ALK +ve Metastatic NSCLC

Medicine Description : A targeted therapy for ALK-positive non-small cell lung cancer (NSCLC), Alunbrig blocks abnormal ALK proteins to slow tumor growth. It is used in patients resistant to prior ALK inhibitors. Taken orally, it improves progression-free survival. Common side effects include nausea, fatigue, cough, and lung inflammation. Close monitoring is needed to manage potential lung-related complications and blood pressure changes.

Product Introduction

Alunbrig (Brigatinib) is a targeted anticancer medicine used to treat adults with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC). It works by blocking abnormal ALK activity that promotes the growth and spread of cancer cells, helping to control the progression of the disease. Alunbrig (Brigatinib) should be taken only as prescribed by a healthcare professional. It may be taken with or without food. Continue the treatment for the period recommended by your doctor and do not stop taking it without medical advice, even if you feel better. Regular medical consultations and laboratory tests may be required to monitor your response to treatment and identify potential side effects.

Common side effects of Alunbrig (Brigatinib) may include diarrhea, fatigue, nausea, skin rash, cough, headache, increased blood pressure, and vomiting. Treatment may also cause changes in blood sugar levels, muscle enzyme levels, pancreatic enzyme levels, or vision. Inform your doctor if any side effect is severe, persistent, or becomes worse. Seek immediate medical attention if you experience new or worsening breathing difficulties, vision changes, severe muscle pain or weakness, or symptoms related to high blood pressure.

Before starting Alunbrig (Brigatinib), inform your doctor about any existing medical conditions and all medicines or supplements you are currently taking. Your doctor may monitor your blood pressure, blood sugar, liver function, and pancreatic enzyme levels during treatment. Report any new or worsening breathing problems, slow heartbeat, vision disturbances, or severe muscle pain promptly. Alunbrig (Brigatinib) may harm an unborn baby, so women who can become pregnant should use effective non-hormonal contraception during treatment as recommended by their healthcare professional.

Uses Of Alunbrig (Brigatinib)

Non-small cell lung cancer

Benefits Of Alunbrig

Alunbrig (Brigatinib) is used in the treatment of non-small cell lung cancer (NSCLC). It works by targeting abnormal ALK activity that contributes to the growth and spread of cancer cells, helping to slow the progression of the disease. Brigatinib may also help manage NSCLC that has spread to the brain, supporting control of cancer in both the body and the brain.

Side Effects Of Alunbrig (Brigatinib)

Most side effects associated with Alunbrig (Brigatinib) are generally manageable and may improve as your body adjusts to the treatment. Speak with your doctor if any side effect persists, becomes severe, or causes concern.

Common Side Effects of Alunbrig (Brigatinib)

  • Diarrhea
  • Fatigue or tiredness
  • Nausea
  • Skin rash
  • Cough
  • Muscle pain
  • Headache
  • High blood pressure
  • Vomiting
  • Breathlessness
How To Use Alunbrig

Take Alunbrig (Brigatinib) exactly as prescribed by your doctor, following the recommended dose and treatment duration. Take it with water and follow your doctor's instructions regarding administration. Alunbrig (Brigatinib) can be taken with or without food.

How Alunbrig (Brigatinib) Works

Alunbrig (Brigatinib) works by targeting and inhibiting an abnormal protein known as anaplastic lymphoma kinase (ALK), which can promote the growth and spread of certain lung cancer cells. By suppressing ALK activity, Alunbrig (Brigatinib) helps slow cancer cell growth and may help control the progression of the disease.

Safety Advice

AlcoholCONSULT YOUR DOCTOR

The safety of consuming alcohol while taking Alunbrig (Brigatinib) is not well established. Consult your doctor before consuming alcohol during treatment.

PregnancyCONSULT YOUR DOCTOR

The safety of Alunbrig (Brigatinib) during pregnancy has not been fully established. There is limited information from studies in pregnant women, and available animal data are not sufficient to determine the potential reproductive risks. Your doctor will assess the expected benefits of treatment against any possible risks before prescribing Alunbrig (Brigatinib).

BreastfeedingCONSULT YOUR DOCTOR

There is limited information available regarding the use of Alunbrig (Brigatinib) during breastfeeding. Consult your doctor before using Alunbrig (Brigatinib). Breastfeeding should not be undertaken during treatment and for at least 1 week after stopping Alunbrig (Brigatinib), as advised by your healthcare professional.

DrivingCONSULT YOUR DOCTOR

The effects of Alunbrig (Brigatinib) on the ability to drive have not been fully established. Avoid driving or operating machinery if you experience symptoms that may affect your concentration, vision, or ability to react. Consult your doctor for guidance.

KidneyCAUTION

Alunbrig (Brigatinib) should be used carefully in patients with kidney problems. Your doctor may recommend a dose adjustment depending on your kidney function.

LiverCAUTION

Patients with liver problems should use Alunbrig (Brigatinib) under medical supervision. Dose modification may be required based on the severity of liver impairment and your doctor's assessment.

Quick Tips
  • Keep all scheduled medical appointments and laboratory tests. Your doctor may monitor your blood pressure, blood sugar, liver function, muscle enzyme levels, and pancreatic enzyme levels throughout Alunbrig (Brigatinib) treatment.
  • Pay close attention to any new or worsening breathing difficulties, particularly during the first week of treatment, and contact your doctor immediately if they occur.
  • Inform your doctor without delay if you experience blurred vision, double vision, or other changes in your eyesight. An eye examination may be recommended if necessary.
  • Minimize exposure to sunlight by wearing protective clothing and using sunscreen while taking Alunbrig (Brigatinib) and for at least 5 days after your final dose.
  • Before starting, stopping, or changing any medication, tell your doctor about all prescription medicines, vitamins, herbal products, and dietary supplements you use to help reduce the risk of drug interactions.
  • Read More About - Alunbrig (Brigatinib) from Pharma Five.
Faq

General Question

Alunbrig Medicine (Brigatinib) is a prescription drug used to treat non-small cell lung cancer (NSCLC) that has spread to other parts of the body.

Alunbrig Medicine works as a tyrosine kinase inhibitor (TKI), blocking specific proteins in cancer cells to stop their growth and spread.

Doctors prescribe Alunbrig Medicine for adults with ALK-positive NSCLC who have previously taken crizotinib or need an alternative targeted therapy.

Alunbrig Medicine is taken orally in tablet form, usually once daily, with or without food.

Common side effects of Alunbrig Medicine include nausea, fatigue, diarrhea, cough, headache, and high blood pressure.

Yes, Alunbrig Medicine may cause lung problems, high blood pressure, slow heart rate, or liver issues. Consult your doctor if severe symptoms appear.

Alunbrig Medicine is typically taken as long as it is effective and well-tolerated, or until the doctor recommends stopping.

It is best to avoid alcohol while taking Alunbrig Medicine, as it may worsen side effects like dizziness and liver toxicity.

Consult your doctor before taking Alunbrig if you are pregnant, as it may pose risks to the baby. Women of reproductive potential should use effective contraception during treatment and for at least 4 months after the final dose.

Yes, Alunbrig Medicine may interact with other drugs, including certain antibiotics, antifungals, and seizure medications. Inform your doctor of all medicines you take.

If you miss a dose of Alunbrig Medicine, take it as soon as you remember, but skip it if your next dose is soon. Do not take two doses together.

Yes, Alunbrig Medicine can be taken with or without food, but taking it with food may help reduce stomach upset.

Avoid grapefruit, excessive sun exposure, and ensure regular health check-ups while taking Alunbrig Medicine.

Store Alunbrig Medicine at room temperature, away from moisture and heat, and keep it out of reach of children.

Alunbrig (Brigatinib) is not officially approved in India but can be accessed via special patient programs or by obtaining a Named Patient Import permit. Pharma Five assists in its procurement.